A non-profit organization dedicated to harnessing the immune system's power to control and potentially cure all types of cancer through research, awareness, and immunotherapy development.

Cancer Research Institute

Founded in 1953, the New York City-based Cancer Research Institute is a nonprofit organization dedicated to extending the lives of cancer patients and reducing cancer-related deaths by fueling the development of smarter, more effective treatments that mobilize our body’s natural immune defenses against all types of cancer.

To accomplish this goal, the Cancer Research Institute supports the most critical research, invests in the development of promising new treatments, and unites the efforts of the field’s leaders worldwide. Through this work, Cancer Research Institute is transforming cancer therapy, enabling patients to live longer, healthier lives free from the fear of cancer. 

For more information visit www.cancerresearch.org.

Cancer Research Institute (CRI)

Did you know? The Cancer Research Institute is ranked among the top 5% of all U.S. rated charities. Give with confidence, and make an impact by donating today to fund lifesaving cancer immunotherapy research: https://bit.ly/44of8ML #CancerResearch #Immunotherapy #CharityRatings #GiveWithConfidence

"CICON is the only meeting I can think of that brings together so many experts in the field to network and collaborate," says Dr. Elizabeth M. Jaffee, Meeting Co-Chair, and Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine. Register to attend #CICON24 by July 15 to receive early-bird pricing! Sign up today, and save: https://bit.ly/3wkc5sQ #CancerResearch #CICON #CancerResearcher #Immunotherapy

Today is Glioblastoma Awareness Day. Understand why GBM is such a deadly type of cancer, hear a patient's story of survival, and discover how CRI-funded researchers are improving patient outcomes, in our new blog post. "Every patient with glioblastoma [whom] I have ever had the privilege of treating is full of resolve, hope, fortitude, and courage," shares CRI Lloyd J. Old STAR Dr. Gavin Dunn of Massachusetts General Hospital. "We owe it to our patients to study their brain cancers and improve their lives." Read more: https://bit.ly/3WaiNeb #GlioblastomaAwarenessDay #GBM #Glioblastoma #CancerResearch #Immunotherapy

“Without a shadow of a doubt, immunotherapy saved my life,” expresses Jeff, a melanoma survivor. Discover the transformative impact of immunotherapy, and gain insight into a patient's perspective, through Jeff's first-hand account of his immunotherapy journey: https://bit.ly/4cQ7Gh9 #CancerResearch #Immunotherapy #CRISummit #Melanoma

Published in Springer Nature Group's Nature Medicine, findings from a small clinical trial suggest that a new cellular immunotherapy approach could be effective in treating metastatic solid tumors. Researchers from The National Institutes of Health, including 2020 American Association for Cancer Research- CRI Lloyd J. Old Award recipient Dr. Steven Rosenberg, genetically engineered lymphocytes from each patient to produce receptors that recognize and attack their cancer cells. The personalized immunotherapy shrank tumors in some patients, and was able to halt tumor regrowth for up to seven months. “It's just the very beginning of converting normal lymphocytes into cells capable of treating the common solid cancers,” says Dr. Rosenberg. “What this study shows is that it's possible. Once you know it’s possible, you work to improve it.” Read more: https://bit.ly/3xUJoUs #ColorectalCancer #Immunotherapy #CancerResearch

Register today to discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide, MD, DPhil!
 
Pancreatic cancer, often termed “the silent killer,” is a relentless and merciless adversary. Ranking as the world’s most lethal form of cancer, it is currently the fourth leading cause of cancer-related deaths in United States.  

Why is pancreatic cancer so difficult to diagnose? What treatment options are available against such a deadly foe? Join us on June 26 for an exclusive, live webinar featuring renowned cancer immunologist, CRI Scientific Advisory Council member, and Clinical Accelerator Investigator, Robert H. Vonderheide, MD, DPhil, from the Abramson Cancer Center of the University of Pennsylvania.

Dr. Vonderheide will delve into these pressing questions and provide a deeper dive into the latest advances in immunotherapy for pancreatic cancer patients. This is a unique opportunity to gain invaluable insights from one of the leading experts in the field. #CancerResearch #PancreaticCancer

CANC

ORG:CANCERRESEARCH

Cancer Research Institute